|
E.V.Surkova
EFFICACY AND SAFETY OF BIPHASIC INSULIN ANALOGUE NOVOMIX -30 IN TYPE 2 DIABETES MELLITUS: FROM CLINICAL RESEARCH TO REAL PRACTICE
|
№16 / 2014
|
|
I.V. Glinkina
ORIGIN STUDY (OUTCOME REDUCTION WITH INITIAL GLARGINE INTERVENTION) 2 YEARS LATER: WHAT’S NEW?
|
№16 / 2014
|
|
A.F. Verbovoy, L.A. Sharonova, R.I. Akhmerova
EFFECTS OF SHORT-TERM THERAPY WITH ROSUVASTATIN ON LIPID METABOLISM IN PATIENTS WITH CORONARY ARTERY DISEASE
|
№16 / 2014
|
|
E.V. Biryukova
FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE - NEW STEP IN THE IMPROVEMENT OF TREATMENT COMPLIANCE IN TYPE 2 DIABETES MELLITUS
|
№16 / 2014
|
|
M.B. Antsiferov, O.M. Koteshkova
DIABETES MANAGEMENT: THE IMPORTANCE OF STRUCTURED SELF-CONTROL
|
№5 / 2014
|
|
N.A. Petunina , I.A. Kuzina
METFORMIN - A RELIABLE PARTNER IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
А.А. Yuryatin
THE SAVOR TRIAL: THE BEGINNING OF THE NEW ERA OF SAFE PHARMACOTHERAPY FOR TYPE-2 DIABETES MELLITUS
|
№5 / 2014
|
|
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
V.I. Kudinov, M.S. Nichitenko, A.I. Chesnikova
THERAPY WITH LIRAGLUTIDE SIGNIFICANTLY IMPROVES GLYCEMIC CONTROL AND HAS POSITIVE IMPACT ON THE CARDIOVASCULAR SYSTEM OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
O.A. Shavlovskaya, MD
FEATURES OF STROKE THERAPY IN DIABETIC PATIENTS
|
№16 / 2013
|
|
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
M.E. Statsenko, M.V. Derevyanchenko
FEATURES OF MANAGEMENT OF HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS: A VIEW OF CARDIOLOGIST
|
№16 / 2013
|
Русский
